ArticleAnimals : an open access journal from MDPI2026
Physiological Responses of European Seabass (
Article in Animals : an open access journal from MDPI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Fish oil has traditionally been the primary source of n-3 long-chain polyunsaturated FA (n-3 LC-PUFA) in aquafeeds but is increasingly being replaced by alternative lipid sources. However, marine carnivorous fish require dietary n-3 LC-PUFA, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which these alternative sources lack. This study assessed the long-term impact of graded levels of dietary EPA+DHA from microalgal oil on European seabass growth, feed utilization, immunological and oxidative status, and muscle FA profile. Six isoproteic (47% protein) and isolipidic (17% lipid) diets containing 0.56%, 0.66%, 0.71%, 0.90%, 1.11%, and 1.27% EPA+DHA were fed to fish (107 g initial weight) for 180 days at 23 °C, followed by a 7-day thermal challenge at 30 °C. At the end of the feeding trial, growth performance, feed utilization, organosomatic indices, blood and innate immune parameters, and oxidative stress were unaffected. Muscle FA composition mirrored that of the diets, and linear correlations were observed between muscle and dietary n-3 LC-PUFA levels. In the thermal challenge, no mortalities occurred, but hematological parameters, immune responses, and oxidative stress were intensified. Muscle FA composition remained unchanged, indicating that a dietary EPA+DHA level of 0.56% appears sufficient to meet physiological needs during an acute temperature challenge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.